Literature DB >> 18497758

Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle.

B G Galvez1, M Sampaolesi, A Barbuti, A Crespi, D Covarello, S Brunelli, A Dellavalle, S Crippa, G Balconi, I Cuccovillo, F Molla, L Staszewsky, R Latini, D Difrancesco, G Cossu.   

Abstract

Different cardiac stem/progenitor cells have been recently identified in the post-natal heart. We describe here the identification, clonal expansion and characterization of self-renewing progenitors that differ from those previously described for high spontaneous cardiac differentiation. Unique coexpression of endothelial and pericyte markers identify these cells as cardiac mesoangioblasts and allow prospective isolation and clonal expansion from the juvenile mouse ventricle. Cardiac mesoangioblasts express many cardiac transcription factors and spontaneously differentiate into beating cardiomyocytes that assemble mature sarcomeres and express typical cardiac ion channels. Cells similarly isolated from the atrium do not spontaneously differentiate. When injected into the ventricle after coronary artery ligation, cardiac mesoangioblasts efficiently generate new myocardium in the peripheral area of the necrotic zone, as they do when grafted in the embryonic chick heart. These data identify cardiac mesoangioblasts as committed progenitors, downstream of earlier stem/progenitor cells and suitable for the cell therapy of a subset of juvenile cardiac diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18497758     DOI: 10.1038/cdd.2008.75

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  35 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Isolation, characterization and differentiation potential of cardiac progenitor cells in adult pigs.

Authors:  A Vanelli; G Pennarossa; S Maffei; B G Galvez; G B Galvez; G Cossu; M Rahaman; F Gandolfi; T A L Brevini
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

3.  Adult cardiac-resident MSC-like stem cells with a proepicardial origin.

Authors:  James J H Chong; Vashe Chandrakanthan; Munira Xaymardan; Naisana S Asli; Joan Li; Ishtiaq Ahmed; Corey Heffernan; Mary K Menon; Christopher J Scarlett; Amirsalar Rashidianfar; Christine Biben; Hans Zoellner; Emily K Colvin; John E Pimanda; Andrew V Biankin; Bin Zhou; William T Pu; Owen W J Prall; Richard P Harvey
Journal:  Cell Stem Cell       Date:  2011-12-02       Impact factor: 24.633

Review 4.  Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity.

Authors:  Domiziana Costamagna; Mattia Quattrocelli; Robin Duelen; Vardine Sahakyan; Ilaria Perini; Giacomo Palazzolo; Maurilio Sampaolesi
Journal:  Cell Mol Life Sci       Date:  2013-08-15       Impact factor: 9.261

Review 5.  Cardiac cell lineages that form the heart.

Authors:  Sigolène M Meilhac; Fabienne Lescroart; Cédric Blanpain; Margaret E Buckingham
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

Review 6.  Stem cell therapy for muscular dystrophies.

Authors:  Stefano Biressi; Antonio Filareto; Thomas A Rando
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 7.  Building Blood Vessels with Vascular Progenitor Cells.

Authors:  Thomas Colunga; Stephen Dalton
Journal:  Trends Mol Med       Date:  2018-05-22       Impact factor: 11.951

8.  Adipokines disrupt cardiac differentiation and cardiomyocyte survival.

Authors:  Laura M Pérez; Beatriz de Lucas; Aurora Bernal; Beatriz G Gálvez
Journal:  Int J Obes (Lond)       Date:  2019-09-23       Impact factor: 5.095

Review 9.  What's new in regenerative medicine: split up of the mesenchymal stem cell family promises new hope for cardiovascular repair.

Authors:  Rosa Vono; Gaia Spinetti; Miriam Gubernator; Paolo Madeddu
Journal:  J Cardiovasc Transl Res       Date:  2012-08-11       Impact factor: 4.132

10.  Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy.

Authors:  Ju Lan Chun; Robert O'Brien; Min Ho Song; Blake F Wondrasch; Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2012-12-27       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.